In the development of breast cancer, the use of inhibitors targeting the colony-stimulating factor 1 receptor (CSF1-R) can eliminate TAMs, leading to effective inhibition of metastasis and angiogenesis, as well as reduction in tumor invasiveness [22]. The gene discussed is CSF1R; the disease is neoplasm.